IGM Biosciences, Inc. (IGMS) Retained Earnings (Accumulated Deficit) USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
IGM Biosciences, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2018 to 2024.
  • IGM Biosciences, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$871 M, a 37.4% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$871 M -$237 M -37.4% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 -$821 M -$246 M -42.9% Dec 31, 2023 10-Q 2024-05-08
Q3 2023 -$761 M -$238 M -45.6% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$699 M -$234 M -50.5% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 -$634 M -$229 M -56.3% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 -$575 M -$221 M -62.5% Dec 31, 2022 10-K 2024-03-07
Q3 2022 -$522 M -$219 M -72.3% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 -$464 M -$205 M -79.3% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 -$406 M -$185 M -84.2% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 -$354 M -$165 M -87.6% Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$303 M -$139 M -84.9% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 -$259 M -$115 M -80.2% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 -$220 M -$95.4 M -76.4% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 -$189 M -$81.4 M -75.9% Dec 31, 2020 10-K 2022-03-29
Q3 2020 -$164 M -$71.5 M -77.4% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 -$144 M Jun 30, 2020 10-Q 2020-08-06
Q1 2020 -$125 M Mar 31, 2020 10-Q 2020-05-07
Q4 2019 -$107 M -$43.1 M -67.3% Dec 31, 2019 10-K 2021-03-30
Q3 2019 -$92.4 M Sep 30, 2019 10-Q 2019-11-07
Q4 2018 -$64.1 M Dec 31, 2018 10-K 2020-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.